Emerging technologies for improving drug and vaccine development for infectious disease

How quickly is the discovery landscape shifting towards new modalities and what challenges do these present for the clinical trials and regulatory systems?
Has the way we handled COVID therapeutics generated long term change in the discovery, development and regulatory systems?


JANET HEMINGWAY CBE | Professor of Tropical Medicine | Liverpool School of Tropical Medicine


JULIANA HAGGERTY | Head of Centre of Excellence – Lipid Nanoparticles | CPI
CLARE BRYANT | Professor | The University of Cambridge
JOSHUA BLIGHT| Chief Executive Officer & Co-Founder | Baseimmune